Has_circ_0010220 regulates the miR-574-3p/IL-6 axis to increase doxorubicin resistance in osteosarcoma

Yanglin Gu1, Guangchang Wang1, Baocai Ran2

  • 1Department of Orthopedics, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, P.R. China.

Abstract

Insights

Hsa_circ_0010220 promotes osteosarcoma (OS) drug resistance by regulating the miR-574-3p/IL-6 axis. Silencing hsa_circ_0010220 can reduce this resistance, highlighting its potential as a therapeutic biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma (OS) is a primary bone cancer with aggressive behavior.
  • Drug resistance, particularly to chemotherapy, presents a significant challenge in OS treatment.
  • Understanding the molecular mechanisms underlying doxorubicin (DOX) resistance is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the functional role of hsa_circ_0010220 in doxorubicin (DOX) resistance in osteosarcoma (OS).
  • To elucidate the underlying molecular mechanism of hsa_circ_0010220 in mediating DOX resistance.
  • To explore the potential of hsa_circ_0010220 as a biomarker for OS treatment.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and ELISA were used to measure hsa_circ_0010220, IL-6, and miR-574-3p levels.
  • Cell Counting Kit-8 assay determined the half-inhibitory concentration (IC50) of DOX.
  • RNA pull-down, RNA immunoprecipitation, and dual-luciferase reporter assays identified molecular interactions.

Main Results:

  • Hsa_circ_0010220 and IL-6 were upregulated, while miR-574-3p was downregulated in DOX-resistant OS tissues and cells.
  • Silencing hsa_circ_0010220 reduced in vitro DOX resistance.
  • Hsa_circ_0010220 sponges miR-574-3p, leading to increased IL-6 expression and enhanced DOX resistance.

Conclusions:

  • Hsa_circ_0010220 promotes OS resistance to DOX through the regulation of the miR-574-3p/IL-6 axis.
  • Targeting hsa_circ_0010220 offers a potential therapeutic strategy for overcoming DOX resistance in OS.
  • Hsa_circ_0010220 may serve as a promising biomarker for predicting and treating OS.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K